Metaphore Pharmaceuticals
Metaphore Pharmaceuticals Inc. is a privately held emerging pharmaceutical company with offices in Fort Lee, New Jersey and St. Louis, MO. The company leverages its expertise to discover and develop small molecule compounds that mimic the function of superoxide dismutase, a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a wide variety of diseases associated with pain and inflammation. Metaphore currently focuses its clinical development efforts in pain, arthritis and inflammatory disorders which represent significant markets in terms of scope and size.
About Metaphore Pharmaceuticals
Founded
2018Estimated Revenue
$0-$1MEmployees
11-50Category
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
2834NAICs Code
32541Location
City
HamburgState
HamburgCountry
GermanyMetaphore Pharmaceuticals
Find your buyer within Metaphore Pharmaceuticals